Research has shown that methionine+ cysteine (M+C) requirements may be higher when chickens are infected with
Eimeria
app. In a 4 × 2 factorial design, broilers (11 to 21 D) were fed one of 4 corn–soybean meal-based diets containing either 0.6, 0.8, 0.9, or 1.0% standardized ileal digestible (SID) M+C; on day 14, broilers from each diet were gavaged with either phosphate-buffered saline (PBS) or a commercial coccidiosis vaccine (at 100 × vaccine dose) which provide a mixture of live
Eimeria acervulina
,
Eimeria maxima
, and
Eimeria tenella
oocysts. Growth performance was recorded from day 11 to 21. Plasma and intestinal luminal samples were collected on days 14 and 21. Intestine lesion scores and fecal oocyst counts were conducted on day 21. Regardless of dietary SID M+C levels, compared to PBS gavaged broilers, the
Eimeria
-challenged broilers had (1) decreased (
P
< 0.05) body weight gain (BWG), feed intake (FI), and gain-to-feed ratio (G:F); (2) increased (
P
< 0.05) intestinal lesion scores and fecal oocyst counts; (3) increased (
P
< 0.05) plasma anti-
Eimeria
IgG, and intestinal luminal total IgA and anti-
Eimeria
IgA concentrations; and (4) increased (
P
< 0.05) levels of duodenum luminal gamma interferon (IFN-γ) and interleukin-10 (IL-10), as well as jejunum and cecum luminal IFN-γ concentrations. Regardless of
Eimeria
challenge, when compared to 0.6% SID M+C, broilers fed ≥0.8% SID M+C had (1) increased (
P
< 0.05) BWG, FI, and G:F and (2) increased (
P
< 0.05) levels of jejunum luminal total IgA. After
Eimeria
challenge, broilers fed 0.8% SID M+C had increased (
P
< 0.05) levels of jejunum luminal anti-
Eimeria
IgA compared to broilers fed diets containing 0.6 and 1.0% SID M+C. Collectively, in 11- to 21-D broilers, the growth suppression caused by
Eimeria
infection could not be mitigated by further increasing dietary M+C alone ≥0.8%. Further research should investigate interactions between dietary M+C and other nutrients for support of immune function and growth in pathogen-challenged broilers.